In another screen of EV proteins aiming at revealing new biomarkers for PC patients, using reverse-phase protein microarrays, a protein signature with prognostic significance was identified, with TGF-β1 being among the proteins presented by EVs with statistical significance in recurrent PC patients (Signore et al., 2021). The gene discussed is TGFB1; the disease is pachyonychia congenita.